Update on the performance and application of basophil activation tests

Current Allergy and Asthma Reports

Volumn 13, Issue 1, 2013, Pages 101-109

  McGowan, Emily C ^a   Saini, Sarbjit ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Basophil; Basophil activation test; CCR3; CD203c; CD63; Drug allergy; Food allergy; Immunotherapy; Venom hypersensitivity

Indexed keywords

ACETYLSALICYLIC ACID; ANTIGEN; ANTIHISTAMINIC AGENT; ATROPINE; BEE VENOM; BETA LACTAM DERIVATIVE; CARBOHYDRATE; CD203C ANTIGEN; CD63 ANTIGEN; CHEMOKINE RECEPTOR CCR3; CIPROFLOXACIN; CONTRAST MEDIUM; DIPYRONE; GADOLINIUM; GLATIRAMER; IMMUNOGLOBULIN E; LEVOFLOXACIN; LYSINE; MEPREDNISONE; MITOGEN ACTIVATED PROTEIN KINASE P38; MOXIFLOXACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PYRAZOLONE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ALLERGENICITY; ALLERGY TEST; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIGEN EXPRESSION; ARTICLE; BASOPHIL; BASOPHIL ACTIVATION TEST; BASOPHIL DEGRANULATION; CARBOHYDRATE ANALYSIS; CELL ACTIVATION; CELL STIMULATION; CROSS REACTION; DIAGNOSTIC ACCURACY; DIARRHEA; DISEASE MARKER; DRUG HYPERSENSITIVITY; DRUG POTENTIATION; DYSPNEA; FLOW CYTOMETRY; FOOD ALLERGY; FUNCTION TEST; HONEYBEE ALLERGY; HUMAN; HYPOTENSION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INSECT ALLERGY; INSECT VENOM ALLERGY; LARYNX EDEMA; MILK ALLERGY; PEANUT ALLERGY; POLLEN ALLERGY; PROTEIN PHOSPHORYLATION; SENSITIVITY AND SPECIFICITY; SKIN TEST; UPREGULATION; URTICARIA; VALIDITY; VOMITING; WHEAT ALLERGY; WHEAT DEPENDENT EXERCISE INDUCED ANAPHYLAXIS;

ALLERGENS; ANTIGENS, CD63; BASOPHILS; BIOLOGICAL MARKERS; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOLOGIC TESTS; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES;

EID: 84872613525     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-012-0324-x     Document Type: Article

References (78)

1. Lichtenstein LM, Norman PS, Winkenwerder WL. Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever. Am J Med. 1968;44(4):514-24.
2. May CD. High spontaneous release of histamine in vitro from leukocytes of persons hypersensitive to food. J Allergy Clin Immunol. 1976;58(3):432-7.
3. Togias AG, Naclerio RM, Warner J, et al. Demonstration of inhibition of mediator release from human mast cells by azatadine base. in vivo and in vitro evaluation. JAMA. 1986;255(2):225-9. (Pubitemid 16146550)
4. Knol EF, Mul FP, Jansen H, Calafat J, Roos D. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol. 1991;88(3 Pt 1):328-38.
5. Schroeder JT. Basophils: emerging roles in the pathogenesis of allergic disease. Immunol Rev. 2011;242(1):144-60.
6. Dvorak AM, Galli SJ, Schulman ES, Lichtenstein LM, Dvorak HF. Basophil and mast cell degranulation: ultrastructural analysis of mechanisms of mediator release. Fed Proc. 1983;42(8):2510-5. (Pubitemid 13043676)
7. Dvorak AM, MacGlashan Jr DW, Morgan ES, Lichtenstein LM. Vesicular transport of histamine in stimulated human basophils. Blood. 1996;88(11):4090-101. (Pubitemid 26399153)
8. Furuno T, Teshima R, Kitani S, Sawada J, Nakanishi M. Surface expression of CD63 antigen (AD1 antigen) in P815 mastocytoma cells by transfected IgE receptors. Biochem Biophys Res Commun. 1996;219(3):740-4. (Pubitemid 26106752)
9. MacGlashan Jr D. Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes. Clin Exp Allergy. 2010;40(9):1365-77.
10. Buhring HJ, Simmons PJ, Pudney M, et al. The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors. Blood. 1999;94(7):2343-56. (Pubitemid 29467682)
11. Buhring HJ, Seiffert M, Giesert C, et al. The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/ phosphodiesterase 3. Blood. 2001;97(10):3303-5.
12. Hauswirth AW, Sonneck K, Florian S, et al. Interleukin-3 promotes the expression of E-NPP3/CD203C on human blood basophils in healthy subjects and in patients with birch pollen allergy. Int J Immunopathol Pharmacol. 2007;20(2):267-78. (Pubitemid 47104847)
13. Monneret G, Boumiza R, Gravel S, et al. Effects of prostaglandin D(2) and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils. J Pharmacol Exp Ther. 2005;312(2):627-34. (Pubitemid 40189560)
14. Macglashan Jr D. Marked differences in the signaling requirements for expression of CD203c and CD11b versus CD63 expression and histamine release in human basophils. Int Arch Allergy Immunol. 2012;159(3):243-52.
15. Hennersdorf F, Florian S, Jakob A, et al. Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation. Cell Res. 2005;15(5):325-35. (Pubitemid 41653928)
16. Ebo DG, Dombrecht EJ, Bridts CH, Aerts NE, de Clerck LS, Stevens WJ. Combined analysis of intracellular signalling and immunophenotype of human peripheral blood basophils by flow cytometry: a proof of concept. Clin Exp Allergy. 2007;37(11):1668-75. (Pubitemid 47609847)
17. Wolanczyk-Medrala A, Barg W, Liebhart J, et al. Validation of basophil CD164 upregulation for pollen allergy diagnosis. Arch Immunol Ther Exp (Warsz). 2010;58(6):459-65.
18. Sturm GJ, Kranzelbinder B, Sturm EM, Heinemann A, Groselj-Strele A, Aberer W. The basophil activation test in the diagnosis of allergy: technical issues and critical factors. Allergy. 2009;64(9):1319-26.
19. • Sturm EM, Kranzelbinder B, Heinemann A, Groselj-Strele A, Aberer W, Sturm GJ. CD203c-based basophil activation test in allergy diagnosis: characteristics and differences to CD63 upregulation. Cytometry B Clin Cytom. 2010;78(5):308-18. This article similarly examined the effect of technical issues on the expression of CD203c.
20. Sousa N, Martinez-Aranguren R, Fernandez-Benitez M, Ribeiro F, Sanz ML. Comparison of basophil activation test results in blood preserved in acid citrate dextrose and EDTA. J Investig Allergol Clin Immunol. 2010;20(6):535-6.
21. Hausmann OV, Gentinetta T, Fux M, Ducrest S, Pichler WJ, Dahinden CA. Robust expression of CCR3 as a single basophil selection marker in flow cytometry. Allergy. 2011;66(1):85-91.
22. Abuaf N, Rostane H, Rajoely B, et al. Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy. Clin Exp Allergy. 2008;38(6):921-8. (Pubitemid 351725844)
23. Eberlein B, Leon Suarez I, Darsow U, Rueff F, Behrendt H, Ring J. A new basophil activation test using CD63 and CCR3 in allergy to antibiotics. Clin Exp Allergy. 2010;40(3):411-8.
24. Monneret G. CCR3 for basophil activation test: a necessary but insufficient step. Clin Exp Allergy. 2010;40(6):953. author reply 954.
25. Monneret G. Is this time for CRTH2/DP2 in a flow cytometric basophil activation test? Clin Exp Allergy. 2008;38(7):1239-40.
26. Boumiza R, Debard AL, Monneret G. The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy. 2005;3:9. (Pubitemid 41522127)
27. Abuaf N, Rostane H, Barbara J, et al. Comparison of CD63 upregulation induced by NSAIDs on basophils and monocytes in patients with NSAID hypersensitivity. J Allergy (Cairo) 2012;2012:580873.
28. Wolanczyk-Medrala A, Gogolewski G, Liebhart J, et al. A new variant of the basophil activation test for allergen-induced basophil CD63 upregulation. The effect of cetirizine. J Investig Allergol Clin Immunol. 2009;19(6):465-73.
29. Mastalerz L, Setkowicz M, Sanak M, Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol. 2004;113(4):771-5. (Pubitemid 38530435)
30. Korosec P, Mavsar N, Bajrovic N, Silar M, Mrhar A, Kosnik M. Basophil responsiveness and clinical picture of acetylsalicylic acid intolerance. Int Arch Allergy Immunol. 2011;155(3):257-62.
31. Gomez E, Blanca-Lopez N, Torres MJ, et al. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy. 2009;39(8):1217-24.
32. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the japanese committee on the safety of contrast media. Radiology. 1990;175(3):621-8. (Pubitemid 20191915)
33. Wolf GL, Arenson RL, Cross AP. A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: comparison of adverse effects. AJR Am J Roentgenol. 1989;152(5):939-44. (Pubitemid 19125116)
34. Brockow K, Romano A, Aberer W, et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a european multicenter study. Allergy. 2009;64(2):234-41.
35. Javaloyes G, Goikoetxea MJ, Sanz ML, Cabrera-Freitag P, Gastaminza G. Basophil activation test in the diagnosis of gadobutrol anaphylaxis. Ann Allergy Asthma Immunol. 2012;108(4):286-7.
36. Pinnobphun P, Buranapraditkun S, Kampitak T, Hirankarn N, Klaewsongkram J. The diagnostic value of basophil activation test in patients with an immediate hypersensitivity reaction to radiocontrast media. Ann Allergy Asthma Immunol. 2011;106(5):387-93.
37. Ben Said B, Berard F, Bienvenu J, Nicolas JF, Rozieres A. Usefulness of basophil activation tests for the diagnosis of IgE-mediated allergy to quinolones. Allergy. 2010;65(4):535-6.
38. Aranda A, Mayorga C, Ariza A, et al. In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy. 2011;66(2):247-54.
39. Rouzaire P, Nosbaum A, Denis L, et al. Negativity of the basophil activation test in quinolone hypersensitivity: a breakthrough for provocation test decision-making. Int Arch Allergy Immunol. 2012;157(3):299-302.
40. Cabrera-Freitag P, Gastaminza G, Goikoetxea MJ, Lafuente A, de la Borbolla JM, Sanz ML. Immediate allergic reaction to atropine in ophthalmic solution confirmed by basophil activation test. Allergy. 2009;64(9):1388-9.
41. Soriano Gomis V, Perez Sempere A, Gonzalez Delgado P, Sempere JM, Niveiro Hernandez E, Marco FM. Glatiramer acetate anaphylaxis: detection of antibodies and basophil activation test. J Investig Allergol Clin Immunol. 2012;22(1):65-6.
42. Ben Said B, Leray V, Nicolas JF, Rozieres A, Berard F. Methylprednisolone-induced anaphylaxis: diagnosis by skin test and basophil activation test. Allergy. 2010;65(4):531-2.
43. Bobadilla-Gonzalez P, Perez-Rangel I, Camara-Hijon C, Garcia-Menaya JM, Sanchez-Vega S. Positive basophil activation test result in a patient with acute urticaria induced by cetirizine and desloratadine. Ann Allergy Asthma Immunol. 2011;106(3):258-9.
44. Matsuo H, Dahlstrom J, Tanaka A, et al. Sensitivity and specificity of recombinant omega-5 gliadin-specific IgE measurement for the diagnosis of wheat-dependent exercise-induced anaphylaxis. Allergy. 2008;63(2):233-6.
45. Fukutomi Y, Itagaki Y, Taniguchi M, et al. Rhinoconjunctival sensitization to hydrolyzed wheat protein in facial soap can induce wheat-dependent exercise-induced anaphylaxis. J Allergy Clin Immunol. 2011;127(2):531-3. e1-3.
46. Chinuki Y, Kaneko S, Dekio I, et al. CD203c expression-based basophil activation test for diagnosis of wheat-dependent exercise-induced anaphylaxis. J Allergy Clin Immunol. 2012;129(5):1404-6.
47. Rubio A, Vivinus-Nebot M, Bourrier T, Saggio B, Albertini M, Bernard A. Benefit of the basophil activation test in deciding when to reintroduce cow's milk in allergic children. Allergy. 2011;66(1):92-100.
48. Ford LS, Bloom KA, Nowak-Wegrzyn AH, Shreffler WG, Masilamani M, Sampson HA. Basophil reactivity, wheal size, and immunoglobulin levels distinguish degrees of cow's milk tolerance. J Allergy Clin Immunol. 2012.
49. Ocmant A, Mulier S, Hanssens L, et al. Basophil activation tests for the diagnosis of food allergy in children. Clin Exp Allergy. 2009;39(8):1234-45.
50. Sabato V, van Hengel AJ, De Knop KJ, et al. Basophil activation reveals divergent patient-specific responses to thermally processed peanuts. J Investig Allergol Clin Immunol. 2011;21(7):527-31.
51. Sabato V, van Hengel AJ, De Knop KJ, et al. Human basophils: a unique biological instrument to detect the allergenicity of food. J Investig Allergol Clin Immunol. 2011;21(3):179-84.
52. Dolle S, Lehmann K, Schwarz D, et al. Allergenic activity of different tomato cultivars in tomato allergic subjects. Clin Exp Allergy. 2011;41(11):1643-52.
53. Raap U, Wieczorek D, Schenck F, Kapp A, Wedi B. The basophil activation test is a helpful diagnostic tool in anaphylaxis to sesame with false-negative specific IgE and negative skin test. Allergy. 2011;66(11):1497-9.
54. Lee JY, Jin HJ, Park JW, Jung SK, Jang JY, Park HS. A case of korean ginseng-induced anaphylaxis confirmed by open oral challenge and basophil activation test. Allergy Asthma Immunol Res. 2012;4(2):110-1.
55. Garcia-Ortega P, Scorza E, Teniente A. Basophil activation test in the diagnosis of sulphite-induced immediate urticaria. Clin Exp Allergy. 2010;40(4):688. author reply 689-90.
56. Kim JH, An S, Kim JE, Choi GS, Ye YM, Park HS. Beef-induced anaphylaxis confirmed by the basophil activation test. Allergy Asthma Immunol Res. 2010;2(3):206-8.
57. Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med. 1978;299(4):157-61. (Pubitemid 8396220)
58. Ebo DG, Hagendorens MM, Bridts CH, De Clerck LS, Stevens WJ. Hymenoptera venom allergy: taking the sting out of difficult cases. J Investig Allergol Clin Immunol. 2007;17(6):357-60. (Pubitemid 350232558)
59. Korosec P, Erzen R, Silar M, Bajrovic N, Kopac P, Kosnik M. Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results. Clin Exp Allergy. 2009;39(11):1730-7.
60. Bonadonna P, Zanotti R, Melioli G, et al. The role of basophil activation test in special populations with mastocytosis and reactions to hymenoptera sting. Allergy. 2012;67(7):962-5.
61. •• Mertens M, Amler S, Moerschbacher BM, Brehler R. Cross-reactive carbohydrate determinants strongly affect the results of the basophil activation test in hymenoptera-venom allergy. Clin Exp Allergy. 2010;40(9):1333-45. This paper used the basophil activation test to assess the biologic activity of cross-reactive carbohydrate determinants.
62. Eberlein B, Krischan L, Darsow U, Ollert M, Ring J. Double positivity to bee and wasp venom: improved diagnostic procedure by recombinant allergen-based IgE testing and basophil activation test including data about cross-reactive carbohydrate determinants. J Allergy Clin Immunol. 2012;130(1):155-61.
63. Khan FM, Ueno-Yamanouchi A, Serushago B, et al. Basophil activation test compared to skin prick test and fluorescence enzyme immunoassay for aeroallergen-specific immunoglobulin-E. Allergy Asthma Clin Immunol. 2012;8(1):1.
64. Ozdemir SK, Guloglu D, Sin BA, Elhan AH, Ikinciogullari A, Misirligil Z. Reliability of basophil activation test using CD203c expression in diagnosis of pollen allergy. Am J Rhinol Allergy. 2011;25(6):e225-31.
65. •• Erzen R, Kosnik M, Silar M, Korosec P. Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study. Allergy. 2012;67(6):822-30. This paper monitored basophil response in 23 patients undergoing venom immunotherapy. They found that basophil activation was decreased one year after completion of immunotherapy.
66. Zitnik SE, Vesel T, Avcin T, Silar M, Kosnik M, Korosec P. Monitoring honeybee venom immunotherapy in children with the basophil activation test. Pediatr Allergy Immunol. 2012;23(2):166-72.
67. Cichocka-Jarosz E, Dorynska A, Pietrzyk JJ, Spiewak R. Laboratory markers of mast cell and basophil activation in monitoring rush immunotherapy in bee venom-allergic children. Immunotherapy. 2011;3(8):1013-7.
68. Van Overtvelt L, Baron-Bodo V, Horiot S, et al. Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy. Allergy. 2011;66(12):1530-7.
69. Lasa Luaces EM, Tabar Purroy AI, Garcia Figueroa BE, et al. Component-resolved immunologic modifications, efficacy, and tolerance of latex sublingual immunotherapy in children. Ann Allergy Asthma Immunol. 2012;108(5):367-72.
70. Swamy RS, Reshamwala N, Hunter T, et al. Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy. J Allergy Clin Immunol. 2012;130(1):215-24. e7.
71. Patil SP, Wang J, Song Y, et al. Clinical safety of food allergy herbal formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: extended phase I study. J Allergy Clin Immunol. 2011;128(6):1259-65. e2.
72. Kopac P, Rudin M, Gentinetta T, et al. Continuous apple consumption induces oral tolerance in birch-pollen-associated apple allergy. Allergy. 2012;67(2):280-5.
73. Bavbek S, Ikinciogullari A, Dursun AB, et al. Upregulation of CD63 or CD203c alone or in combination is not sensitive in the diagnosis of nonsteroidal anti-inflammatory drug intolerance. Int Arch Allergy Immunol. 2009;150(3):261-70.
74. De Week AL, Sanz ML, Gamboa PM, et al. Diagnosis of immediate-type beta-lactam allergy in vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter study. J Investig Allergol Clin Immunol. 2009;19(2):91-109.
75. Kim MS, Cho YJ. Flow cytometry-assisted basophil activation test as a safe diagnostic tool for aspirin/NSAID hypersenstivity. Allergy Asthma Immunol Res. 2012;4(3):137-42.
76. Rodriguez-Trabado A, Camara-Hijon C, Ramos-Cantarino A, et al. Basophil activation test for the in vitro diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity. Allergy Asthma Proc. 2008;29(3):241-9.
77. Peternelj A, Silar M, Bajrovic N, et al. Diagnostic value of the basophil activation test in evaluating hymenoptera venom sensitization. Wien Klin Wochenschr. 2009;121(9-10):344-8.
78. Frezzolini A, Cadoni S, De Pita O. Usefulness of the CD63 basophil activation test in detecting anisakis hypersensitivity in patients with chronic urticaria: diagnosis and follow-up. Clin Exp Dermatol. 2010;35(7):765-70.